Integrated Advisors Network’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Integrated Advisors Network’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-36,687	Closed	-$882K	–	651
2022 Q3	$882K	Sell	36,687 -1,497	-4%	-$38.7K	0.06%	288
2022 Q2	$1.01M	Buy	38,184 +2,101	+6%	+$55.5K	0.07%	276
2022 Q1	$960K	Buy	36,083 +5,427	+18%	+$140K	0.06%	314
2021 Q4	$830K	Buy	30,656 +2,103	+7%	+$55.2K	0.05%	326
2021 Q3	$736K	Buy	28,553 +801	+3%	+$21K	0.05%	333
2021 Q2	$718K	Buy	+27,752	New	+$718K	0.05%	289

Other funds holding FTXH

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

WFA

WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.03% 1-Year Est. Return

KNW

Kesler Norman & Wride Ogden, Utah $631M AUM 27.63% 1-Year Est. Return

Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GSIAS

Garden State Investment Advisory Services Red Bank, New Jersey $455M AUM 25.41% 1-Year Est. Return

Integrated Advisors Network's FTXH Position: Q4 2022 in Review

Integrated Advisors Network sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q4 2022, closing a stake of 36,687 shares — an estimated $882K sold.

Integrated Advisors Network first reported a position in FTXH in Q2 2021 and held it in 6 quarters. The position peaked at $1.01M in Q2 2022. 34 funds tracked by Wall St. Rank hold FTXH as of Q4 2022.

Integrated Advisors Network reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q4 2022 after selling out during the quarter.
Integrated Advisors Network sold 36,687 First Trust Nasdaq Pharmaceuticals ETF shares in Q4 2022, an estimated $882K.
Integrated Advisors Network first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2021 and held it in 6 quarters.
Integrated Advisors Network's First Trust Nasdaq Pharmaceuticals ETF position peaked at $1.01M in Q2 2022.
34 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q4 2022.

Based on Integrated Advisors Network's 13F filing for Q4 2022, filed 27 Jan 2023.